Glymira Tablet 500 mg contains Imeglimin Hydrochloride, a novel oral antihyperglycemic agent used in the management of type 2 diabetes mellitus. It is designed to improve glycemic control by targeting multiple mechanisms involved in the pathophysiology of diabetes. Glymira works by enhancing insulin sensitivity, improving pancreatic beta-cell function, and reducing hepatic glucose production, making it an effective treatment option for patients who require better blood sugar regulation alongside diet and exercise.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glymira Tablet 500 mg is indicated for:

• Type 2 Diabetes Mellitus: As monotherapy or in combination with other oral antihyperglycemic agents when diet and exercise alone do not provide adequate glycemic control.

• Improvement of Glycemic Control: Reduces fasting plasma glucose and postprandial glucose levels.

• Glymira should always be used under the supervision of a registered healthcare professional.

Therapeutic Class

• Oral Antihyperglycemic Agents

• Glucose-Lowering Drugs

Pharmacology

Imeglimin Hydrochloride, the active ingredient in Glymira, is a first-in-class tetrahydrotriazine agent with a unique mechanism of action targeting three key aspects of type 2 diabetes:

1. Improvement of Insulin Sensitivity: Enhances insulin action in muscle and liver tissues, increasing glucose uptake and utilization.

2. Enhancement of Pancreatic Beta-Cell Function: Stimulates glucose-dependent insulin secretion, improving the body’s natural insulin response without causing hypoglycemia.

3. Reduction of Hepatic Glucose Production: Decreases excessive glucose release from the liver, contributing to lower fasting glucose levels.

Glymira acts on the mitochondria of pancreatic beta-cells and liver cells, helping restore normal cellular function and improving overall glycemic control.

Dosage & Administration

• The usual recommended dose is 500 mg orally, twice daily, with or without food.

• The dosage may be adjusted based on clinical response and renal function.

• Tablets should be swallowed whole with water.

• Glymira should be taken consistently at the same time each day for optimal efficacy.

Special Populations:

• Renal Impairment: Dose adjustment may be necessary depending on the severity of renal dysfunction.

• Elderly Patients: No specific dose adjustment is generally required but monitoring is recommended.

Contraindications

Glymira Tablet 500 mg is contraindicated in patients with:

• Known hypersensitivity to Imeglimin Hydrochloride or any excipients in the formulation

• Severe renal impairment (as per product-specific guidance)

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Glymira is generally well tolerated. Some patients may experience:

• Gastrointestinal disturbances such as nausea, diarrhea, or abdominal discomfort

• Mild headache or dizziness

• Rarely, hypoglycemia, especially when used in combination with other antihyperglycemic agents

Precautions & Warnings

• Monitor blood glucose levels regularly to avoid hyperglycemia or hypoglycemia.

• Use with caution in patients with renal or hepatic impairment.

• Patients should maintain lifestyle modifications including diet and exercise to maximize the efficacy of Glymira.

Pregnancy & Lactation

• Pregnancy: Use only if potential benefits outweigh potential risks; clinical data are limited.

• Lactation: Caution is advised as it is unknown whether Imeglimin is excreted in human milk.

Storage Conditions

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.